Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The voltage-gated sodium channel protein type 5 subunit alpha (NaV1.5) is a pore-forming subunit of the cardiac sodium channel, encoded by the SCN5A gene. Primarily expressed in cardiac muscle cells, it plays a critical role in generating and propagating electrical signals necessary for normal heart rhythm by mediating the fast influx of sodium ions during phase 0 of the cardiac action potential. Mutations in SCN5A are associated with various inherited arrhythmia syndromes.
Sodium channel blockade (modulators)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated Sodium Channel Protein Type 5 Subunit Alpha (NaV1.5).